The OSS is expected to interact with hematologists/oncologists, medical oncologists, academic oncologists, surgical oncologists and gynecologic oncologists, as necessary, and this interaction takes place, but is not limited to, oncology groups, hospital oncology groups, academic centers, pathology labs, interventional radiology suites and surgery centers. The OSS is the primary commercial owner of oncology-directed opportunities within the assigned geography and partners with the Territory Business Manager (TBM) on integrated account strategies involving pathology, laboratories, hospital and health-system stakeholders.